scorecardresearchZydus Lifesciences Share Price Live NSE, BSE, Today - Zydus Lifesciences

Zydus Lifesciences

BSE: 532321 | NSE: ZYDUSLIFE | ISIN: INE010B01027 | SECTOR: Biotechnology & Drugs

964.50 -29.55 (-2.97%)

12 Apr 2024, 09:59 (IST)
  • Open

    990.55
  • High

    997.15
  • Low

    958.50
  • Prev Close

    994.05
  • P/E

    -
  • Median P/E

    -
  • P/B

    -
  • Median P/B

    -
  • Market Cap

    970.51B
  • Volume

    32.46K
  • Vol. (20 day Avg.)

    0
  • PEG

    -
  • Div.Yield

    -
  • Bid

    -
  • Ask

    -

Company Description

  • Biotechnology & Drugs
  • BSE

    532321
  • NSE

    ZYDUSLIFE
  • ISIN

    INE010B01027

Zydus Lifesciences Limited is an India-based global life sciences company that discovers, develops, manufactures and markets a broad range of healthcare therapies. The Company is engaged in the business of integrated pharmaceutical operations. Its product portfolio includes active pharmaceutical ingredients (API), human formulations, animal health and veterinary, health, and wellness products. Its products include India formulations, Generics and Zydus biologics. The Company's products include Lipaglyn and Bilypsa (Saroglitazar), Ujvira (Trastuzumab emtansine biosimilar), Exemptia (Adalimumab biosimilar), Vivitra (Trastuzumab biosimilar) and Bryxta (Bevacizumab biosimilar). Its Zydus biologics covers various therapeutic areas, such as oncology, autoimmune disease, nephrology, inflammation, rheumatology, hepatology and infectious illnesses, among others. The Company has a global presence and markets its products in the United States, India, Europe and emerging markets.

Company Officers

  • Nitin Parekh

    Chief Financial Officer
  • Dhaval Soni

    Company Secretary, Chief Compliance Officer
  • Sharvil Patel

    Managing Director, Executive Director
  • Ganesh Nayak

    Executive Director